Reply to W.H. Tong et al

Affiliations

¹ Theodore W. Laetsch, MD, Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Ranjan Tiwari, MSc, Novartis Healthcare Pvt Ltd, Hyderabad, India; and Stephan A. Grupp, MD, PhD, Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Comment

Theodore W Laetsch et al. J Clin Oncol. 2023.

. 2023 May 1;41(13):2451-2453.

doi: 10.1200/JCO.23.00187. Epub 2023 Mar 10.

¹ Theodore W. Laetsch, MD, Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Ranjan Tiwari, MSc, Novartis Healthcare Pvt Ltd, Hyderabad, India; and Stephan A. Grupp, MD, PhD, Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA, Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

No abstract available

Comment on